Abolition of substrate-dependent currents by tyrosine mutation in the transmembrane domain of glutamate transporter  by Choi, Inyeong & Chiu, Shing Yan
Abolition of substrate-dependent currents by tyrosine mutation in the
transmembrane domain of glutamate transporter
Inyeong Choi
a
, Shing Yan Chiu
b;
*
a
Developmental Biology Program, University of Wisconsin, 283 Medical Sciences Building, 1300 University Avenue, Madison, WI 53706, USA
b
Department of Neurophysiology, University of Wisconsin, 283 Medical Sciences Building, 1300 University Avenue, Madison, WI 53706, USA
Received 10 January 1997
Abstract By site-directed mutagenesis we examined the roles of
tyrosine residues (Tyr
127
) in the putative transmembrane domain
of rat glutamate transporter (GLAST). When expressed in
Xenopus oocytes, Y127F mutant protein, which was localized in
plasma membranes of oocytes, completely abolished glutamate
uptake currents but did not affect the intrinsic substrate-
independent currents. Coexpression of wild type and mutant
transporters supports that the Y127F mutation did not elicit
glutamate efflux. The efflux of glutamate by wild type or Y127F
mutant transporters was measured under the condition of ion
perturbation where transporters run in the reverse direction.
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1. Introduction
High-a¤nity glutamate transporters are known to modulate
the amplitude and time course of synaptic transmission [1^3].
These transporters are also known to have pathological im-
portance because altered levels of extracellular neurotransmit-
ter concentration are potential causes of neurodegenerative
disease. Cloning glutamate transporter cDNAs (GLT-1,
GLAST, EAAC1, and EAAT4 [4^7]) facilitated understand-
ing of the cellular localization of these transporters [8,9] and
functional properties [10]. Site-directed mutagenesis study also
revealed that polar or charged amino acid residues appear to
be involved in glutamate or cosubstrate binding [11,12]. In
this study, we examined three amino acid residues (Tyr
127
,
Phe
253
, and Leu
325
) located in the transmembrane domains
of GLAST. These residues are conserved in all glutamate
transporter isoforms, but substituted with other amino acid
residues found at equivalent positions in the structurally re-
lated neutral amino acid transporter ASC1 [13] and SATT
[14]. Tyr
127
has an excellent nucleophilic hydroxyl group,
Phe
253
is conserved in the homologous region of the bacterial
glutamate transporter GLTP [2,3], and Leu
325
is replaced by a
charged histidine in the corresponding site of ASC1. The func-
tional impact of the mutant proteins was examined in the
Xenopus oocyte system with a two electrode voltage clamp.
2. Materials and methods
2.1. Site-directed mutagenesis
GLAST cDNA was isolated from adult rat optic nerve mRNA by
RT-PCR with primers, which was designed on the published GLAST
sequence [5]. The forward primer is 5P-CAGTCACAGAATCA-
GAAAAGT-3P (72^92); the reverse primer is 5P-ATCAGAGTAGG-
GAGGAAAGAG-3P (1911^1931). Following reverse transcription,
PCR was performed with denaturation at 95³C for 1 min, annealing
and extension at 65³C for 1 min, and 7 min at 65³C for the last
extension. The single 1.8 kb PCR product was cloned into the oocyte
expression vector pGH19 [15]. We sequenced our PCR-derived optic
nerve GLAST cDNA and found four di¡erences in amino acids from
the published sequences: from Phe to Leu at 50, from Asn to Lys at
275, from Leu to Val at 302, and from Thr to Ala at 432. These are
located on the cytoplasmic or extracellular domain. Our GLAST
nonetheless retains electrophysiological properties similar to those of
the previous one. Site-directed mutagenesis was performed as de-
scribed [16]. The mutagenic primers are GTGGTCTATTTCATGAC-
TACC (Y127F), CTTCTTCATGTGCCTAGGCTTCGTGAT
(F253L), and GTCATCGTCGGTCACCTCATTCATGCC (L325H).
Mutation was done using the Trans Oligo AatII/EcoRV selection
primer (Clontech).
2.2. Electrophysiology
The defolliculated oocytes (stages V and VI) were injected with
water or 10^20 ng of wild type or mutant cRNA. Oocytes were in-
cubated in ND96 bu¡er, supplemented with 50 Wg/ml gentamicin, 2.5
mM sodium pyruvate and 5% heat-inactivated horse serum [17]. In-
jected oocytes were maintained for 2^5 days at 18³C before use. Mi-
croelectrodes were ¢lled with 1 M KCl and had a resistance of 6 2
6M. Steady state glutamate currents were measured by subtracting
the currents in the presence of glutamate with the currents in the
absence of glutamate. To monitor glutamate e¥ux, GLAST-express-
ing oocytes were tested under condition of ion perturbation where
transporters run in the reverse direction, as described [18]. Brie£y,
oocytes were bathed in ND96 bu¡er and clamped at 350 mV. The
medium was then replaced with a modi¢ed bu¡er (98 mM KCl, 0 mM
NaCl, 1 mM MgCl
2
, 1.8 mM CaCl
2
, 5 mM HEPES, pH 7.4) contain-
ing 10 mM L-glutamate. After currents were stabilized, L-glutamate
was removed from the medium. 15 ng of wild type or Y127F cRNA
alone or both were injected for experiments of glutamate e¥ux. Data
are expressed as meanþS.E.
2.3. Western blot
Oocyte plasma membranes were isolated as described [19]. Proteins
were separated by 12% SDS-PAGE, transferred to nitrocellulose, and
pre-incubated (1 h) in blocking bu¡er (5% non-fat dried milk, 0.05%
Tween 20 in 50 mM Tris, pH 7.4; 150 mM NaCl). Membranes were
then incubated with an antibody speci¢c to GLAST (0.6 Wg/ml, pro-
vided by Je¡erey Rothstein [20]). After several washes with TBS, blots
were incubated with horseradish peroxidase (HRP)-conjugated anti-
rabbit IgG (1:2000) for 1 h. Blots were washed and developed by
chemiluminescence (Amersham).
2.4. Immunocytochemistry
Oocytes were ¢xed overnight in 4% paraformaldehyde, embedded in
para¤n, and sectioned at a thickness of 6 Wm. Sections were treated
with 3% hydrogen peroxide, 0.1% Triton X-100 in TBS for 20 min.
Sections were pre-incubated (1 h) with 4% normal goat serum, 0.1%
Triton X-100 in TBS, and then incubated for 48 h with an antibody to
GLAST (0.6 Wg/ml). After 1 h incubation with biotinylated anti-rabbit
IgG (1:200, Vector Lab), sections were incubated (30 min) with avi-
din/peroxidase solution from the Vecstatin kit (1:100). The chromo-
genic reaction was performed with 0.5% diaminobenzidine, 0.1% hy-
drogen peroxide.
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3. Results and discussion
3.1. Expression of wild type and mutant transporters in
Xenopus oocytes
Immunoblot of the oocyte plasma membranes shows that
oocytes injected with wild type, Y127F or F253L cRNA ex-
pressed a relatively broad band with an apparent molecular
mass of 60^70 kDa (Fig. 1). This heterogeneous band has
been seen previously with antibodies to glutamate transporters
[20,21]. Higher molecular weight bands probably represent
aggregates of the transporters [22]. L325H cRNA-injected oo-
cytes failed to reveal immunoreactive bands seen in wild type
GLAST-injected oocytes. Water-injected control oocytes
showed no immunoreactivity.
3.2. Electrophysiological properties of mutant transporters
Wild type GLAST in this study reveals similar electrophys-
iological properties of the previously cloned GLAST [23,24].
Application of L-Glu induced a steady state inward current
(V100 nA at 390 mV) in oocytes injected with wild type
GLAST cRNA (Fig. 2A). The inward current was also
evoked by application of D-Asp, but not by the stereoisomer
D-Glu (data not shown). Y127-injected oocytes (10^40 ng/oo-
cyte) evoked no detectable currents (ns 15), whereas F253L-
injected oocytes had a glutamate-induced inward current sim-
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Fig. 1. Immunoblot of crude SDS extract of membranes prepared
from Xenopus oocytes injected with wild type or mutant GLAST
cRNAs. Proteins were immunoblotted with a¤nity-puri¢ed antibody
to GLAST [20].
Fig. 2. A: The steady state inward currents evoked by application of 100 WM L-glutamate (holding potential: 390 mV). Bars: the duration of
glutamate application. B: a: The current-voltage relation of uninjected (¢lled circles), wild type (¢lled squares), Y127F (open circles), or F253L
(open triangles) cRNA-injected oocytes. The current was obtained in the absence of glutamate at various holding potentials. b: Voltage depend-
ence of substrate-independent current between 3100 and +40 mV. The substrate-independent current was acquired by subtracting the mean val-
ue of current in uninjected control oocytes from the current value in oocytes expressing wild type or mutant GLAST in the absence of gluta-
mate.
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ilar to wild type (n=9). Currents in Y127F mutants again
failed to be induced with the application of D-Asp, or L-Ala,
which is a substrate of neutral amino acid transporters (data
not shown). However, mutations did not a¡ect an intrinsic
glutamate-independent ionic current of GLAST (Fig. 2B).
This substrate-independent current, measured by subtracting
currents of water-injected oocytes from those of GLAST-in-
jected oocytes in the absence of glutamate [25], remained un-
changed in oocytes expressing Y127F or F253L mutants. The
apparent a¤nity for glutamate of F253L mutants showed no
signi¢cant di¡erence from wild type (data not shown). Oo-
cytes injected with L325H mutant cRNA became unhealthy
and died by 72 h after injection.
3.3. Glutamate e¥ux
E¥ux of glutamate in oocytes expressing wild type or mu-
tant GLAST was assayed by measuring the outward current
in the presence of high [K

] and low [Na

] in the external
medium [26]. For control experiments, oocytes were ¢rst put
in the normal ND-96 medium (Fig. 3A). Application of 100
WM L-Glu, at which the currents are almost saturated (data
not shown), evoked an inward current in oocytes expressing
wild type alone or wild type plus Y127F mutant GLAST. The
average amplitude of currents was 80.75 nA for wild type
alone (n=4) and 74.75 nA for wild type and Y127F mutant
(n=4) at a holding potential of 390 mV, showing no signi¢-
cant di¡erence. Fig. 3B shows an outward current in wild type
GLAST-expressing oocytes at 350 mV when glutamate was
removed from a medium containing 98 mM K

and 0 mM
Na

. This indicates that the glial type transporter GLAST,
similar to the neuronal transporter EAAC1 [18], could run in
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Fig. 4. Immunocytochemistry of oocytes expressing Y127F mutant
GLAST. Sections of 6 Wm were incubated with antibody against
GLAST and stained using horseradish peroxidase-conjugated anti-
rabbit immunoglobulin. Large arrows: plasma membranes with nor-
mal microvillus structure. Small arrows: vitelline envelope. Y: yolk
platelets. *: the cortical granules.
Fig. 3. Reverse transport of glutamate by wild type and Y127F mutant GLAST. A: An inward current in oocytes expressing wild type GLAST
alone (n=4) or wild type plus Y127F mutant (n=4). The current was measured in the normal ND96 medium, with 100 WM L-glutamate at the
390 mV. B: Reverse transport of glutamate. Oocytes expressing wild type alone or wild type plus Y127F were placed in a bu¡er (98 mM K

,
0 mM Na

) containing 10 mM glutamate. The outward current was observed at 350 mV when glutamate was removed from the medium, as
previously described [18].
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the reverse direction in the presence of high extracellular Na

and K

. Our results are similar to those seen with the gluta-
mate transporter in retinal Mu
ë
ller glial cell [27,28]. Negligible
currents were induced in oocytes injected with water or Y127F
cRNA alone under the same experimental condition. The
average amplitude of this outward current was 64 nA for
wild type alone and 59.5 nA for coexpression of wild type
and mutant. The ratio of the outward current to the inward
current was therefore 0.79 for wild type alone and 0.78 for
coexpression, suggesting no signi¢cant e¡ect of mutant
GLAST on the outward currents by wild type.
3.4. Localization of Y127F mutant transporter
Y127F mutant transporters were correctly targeted to the
plasma membrane of oocytes (Fig. 4). An uninjected control
oocyte was not immunoreactive. The dark-stained cortical
pigment granules adjacent to the plasma membrane were
not immunoreactive. The granule staining was strong in the
animal pole and weak in the vegetal pole, and remained active
even after treatment with hydrogen peroxide (3%) to quench
peroxidase activity. Our immunocytochemistry result, in com-
bination with the intact substrate-independent currents in
Y127F-expressing oocytes, suggests that the absence of cur-
rent is not due to a conformational change caused by the
amino acid substitution. The exchange of tyrosine for phenyl-
alanine is relatively conservative. They are aromatic amino
acids with similar hydrophobicity but di¡erent hydrophilicity
due to the hydroxyl group in tyrosine. Further, the membrane
conductance of Y127F-expressing oocytes reveals no signi¢-
cant di¡erence from the membrane conductance of wild type-
expressing oocytes (Fig. 2B,a). Alternatively, we do not ex-
clude the possibility that mutation at Tyr
127
led to a `non-
conducting' transporter, without a¡ecting glutamate binding.
In this case, mutation might a¡ect the `turning' or `operation'
of the transporter rather than glutamate binding. A recent
report by Sto¡el's group shows that mutation of Tyr
405
also
abolished glutamate currents [11]. While Tyr
405
resides in the
intracellular domain, Tyr
127
in this study is located in the
transmembrane domain. Our immunoblot indicates that the
oocytes injected with L325H mutant cRNA do not express
transporter proteins. Instead, we observe high molecular
weight bands, which appear to be aggregates of GLAST pro-
teins. L325H protein failed to target to the plasma membrane
(data not shown). We believe that this failure was caused by
the conformational change deriving from a positively charged
histidine. This substitution would create a di¡erent charge
environment in the `pore' region. Nonetheless, it is unclear
how this cryptic activity in L325H mutants caused a low
viability in oocytes. In conclusion, we demonstrate that muta-
tion at Tyr
127
abolished a glutamate-induced current. This
residue appears to be critical for glutamate transport in glu-
tamate transporters.
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